⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Complement Inhibitors (Intracellular/Complosome-Targeted)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-29 — Complosome as a key modulator of cellular senescence, aging and age-related diseases.: Review consolidates the complosome (intracellular C3/C5) as a cross-cutting modulator of cellular senescence, inflammaging, and multiple aging hallmarks via mTOR/NF-κB/AMPK crosstalk, and nominates intracellular-selective complement inhibitors, RNAi, PROTACs, and targeted nanodelivery as candidate aging interventions — mechanistic synthesis, no outcome study yet. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Complosome as a key modulator of cellular senescence, aging and age-related diseases.
29-jul-2026
novelty 3
per-area 3
strengthens